Pharmacology & Pharmacy

Vol.7 No.3(2016), Paper ID 64381, 9 pages

DOI:10.4236/pp.2016.73016

 

Effects of Lifestyle Intervention Performed by Community Pharmacists on Glycemic Control in Patients with Type 2 Diabetes: The Community Pharmacists Assist (Compass) Project, a Pragmatic Cluster Randomized Trial

 

Hiroshi Okada, Mitsuko Onda, Masaki Shoji, Kazuhiko Kotani, Takeo Nakayama, Yasushi Nakagawa, Naoki Sakane

 

Department of Preventive Medicine, Clinical Research Institute for Endocrine and Metabolic Disease, National Hospital Organization Kyoto Medical Center, Kyoto, Japan
Clinical Laboratory of Practical Pharmacy, Osaka University of Pharmaceutical Sciences, Osaka, Japan
Clinical Laboratory of Practical Pharmacy, Osaka University of Pharmaceutical Sciences, Osaka, Japan
Division of Community and Family Medicine, Jichi Medical University, Tochigi, Japan
Department of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan
Polon Company, Kobe, Japan
Department of Preventive Medicine, Clinical Research Institute for Endocrine and Metabolic Disease, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

 

Copyright © 2016 Hiroshi Okada, Mitsuko Onda, Masaki Shoji, Kazuhiko Kotani, Takeo Nakayama, Yasushi Nakagawa, Naoki Sakane et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Okada, H. , Onda, M. , Shoji, M. , Kotani, K. , Nakayama, T. , Nakagawa, Y. and Sakane, N. (2016) Effects of Lifestyle Intervention Performed by Community Pharmacists on Glycemic Control in Patients with Type 2 Diabetes: The Community Pharmacists Assist (Compass) Project, a Pragmatic Cluster Randomized Trial. Pharmacology & Pharmacy, 7, 124-132. doi: 10.4236/pp.2016.73016.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.